Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCardiologyVascular biology Open Access | 10.1172/jci.insight.202638

Vascular smooth muscle RbFox2 regulates the cytoskeleton and arterial stiffness by a RhoBTB1-Cullin-3 mechanism

Gaurav Kumar,1 Nisita Chaihongsa,1 Daniel T. Brozoski,1 Daria Golosova,1 Ibrahim Vazirabad,1 Ko-Ting Lu,1 Kelsey K. Wackman,1 Ravi K. Singh,2 and Curt D. Sigmund1

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Kumar, G. in: PubMed | Google Scholar |

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Chaihongsa, N. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Brozoski, D. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Golosova, D. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Vazirabad, I. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Lu, K. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Wackman, K. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Singh, R. in: PubMed | Google Scholar

1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, United States of America

2Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, United States of America

Find articles by Sigmund, C. in: PubMed | Google Scholar |

Published April 2, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.202638.
Copyright © 2026, Kumar et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 2, 2026 - Version history
View PDF
Abstract

The RhoBTB1-Cullin3 (CUL3) pathway in smooth muscle cells (SMCs) controls the ubiquitination and proteasomal degradation of target proteins that regulate vasodilation, vasoconstriction, and the actin cytoskeleton, and through this blood pressure (BP) and arterial stiffness. Using proximity labelling coupled with mass spectrometry in A7R5 SMCs, we identified proteins which bound to the C-terminal half of RhoBTB1 which functions as an adapter to deliver substrates to CUL3. We examined the physiological relevance of one of these substrates, RbFox2. Co-immunoprecipitation validated the interaction of RbFox2 with RhoBTB1. RbFox2 expression was elevated in response to inhibition of the ubiquitination-proteasomal pathway, CUL3-deficiency, and RhoBTB1 inhibition by either siRNA or angiotensin II (ANG). RbFox2 was ubiquitinated in a RhoBTB1- and CUL3-dependent manner suggesting its regulation through the RhoBTB1-CUL3-dependent ubiquitin-proteasome pathway. Inhibition of RbFox2 impaired the actin cytoskeleton in A7R5 cells and in primary SMC from RbFox2Flox/Flox (RbFox2F/F) mice and decreased the levels of globular and filamentous actin. ANG increased BP and arterial stiffness of RbFox2F/F mice, but the progression of arterial stiffness was halted after SMC-specific RbFox2 deletion despite a continued rise in BP. We conclude that RhoBTB1 and RbFox2 are important regulators of arterial stiffness through a mechanism that influences cytoskeletal integrity.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View Extended Dataset 1 (Proteomic Data)

View Extended Dataset 2 (IsoSeq Data)

View

Version history
  • Version 1 (April 2, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts